News

Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared

ANN ARBOR, MI / ACCESSWIRE / June 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

2 years ago

Forza Innovations Inc. Announces $480,000 Financing Agreement

SAN DIEGO, CA, June 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Forza Innovations Inc.  (OTC Pink: FORZ) (the “Company”)…

2 years ago

Renibus Therapeutics Announces Positive Interim Data from RBT-1 Phase 2 Trial

RBT-1 met primary endpoint of increasing the expression of biomarkers of cytoprotective preconditioning; positive data supports the potential for RBT-1…

2 years ago

Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR

SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) --  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk…

2 years ago

Chalice Brands Ltd. Announces Delay in Filing of Annual Financial Statements

PORTLAND, Ore., June 15, 2022 (GLOBE NEWSWIRE) -- Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (the “Company” or “Chalice Brands”),…

2 years ago

Oregon’s Bio Boom: ‘Pandemic Ready’ Industry Surpasses $15 Billion Footprint in Oregon Creating More Firms, More Jobs, More Investment, More Discovery, More Innovation

Oregon Bioscience Association releases its new economic impact report at https://www.oregonbio.org/about/reports/ which points to continued robust growth during the pandemic,…

2 years ago

Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004

GROTON, Conn.--(BUSINESS WIRE)--Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries,…

2 years ago

Enovis™, Formerly Branded DJO®, Introduces Arsenal Ankle Plating System™

A comprehensive ankle plating portfolio, designed with the proven technology of Arsenal Foot Plating System, expands offerings to address both…

2 years ago

Study Plan of AlzeCure’s Phase II Clinical Study in Neuropathic Pain with Non-Opioid ACD440 Now Available

STOCKHOLM, SE / ACCESSWIRE / June 15, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a…

2 years ago

Poko Innovations Debuts its Poko Skincare Range for PCOS Skin Concerns on Virgin Media’s Popular Ireland Breakfast Show Ireland AM

LONDON / DUBLIN, UK / ACCESSWIRE / June 15, 2022 / (POKO:CSE): an award-winning UK-based collection of CBD-focused companies that…

2 years ago